|
Nov 8
|
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings
|
|
Nov 8
|
Collegium to Participate in Upcoming Investor Conferences
|
|
Nov 7
|
Collegium Reports Third Quarter 2023 Financial Results
|
|
Nov 1
|
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Aug 28
|
Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
|
|
Aug 24
|
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
|
|
Apr 27
|
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?
|